Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation.

Ann Hematol

Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Torino, Torino, Italy.

Published: September 2020

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00277-020-04180-6	DOI Listing

Publication Analysis

netupitant-palonosetron prevent

prevent chemotherapy-induced

chemotherapy-induced nausea

nausea vomiting

vomiting multiple

multiple myeloma

myeloma patients

patients receiving

receiving high-dose

high-dose melphalan

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!